H.C. Wainwright analyst Andrew Fein raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $35 from $30 and keeps a Buy rating on ...

Sadly, some of the strongest characters that stand out in the books didn't make it into any of the Harry Potter movies.

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

Cat McCarrey I spent too long trying to puzzle out this week’s mystery pick. Here are the hints provided: It’s an Eighties ...

Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for ...

Jason Watkins and Robson Green star in this four-part Channel 5 thriller about a retired detective (Watkins) whose suspicions ...

Harry Potter introduced viewers to a world of wizards, spells, and fantastical creatures. Based on a book series of the same ...